FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD.
Bicalutamide Tablets USP 50mg

Bicalutamide Tablets USP 50mg

Send Inquiry
We introduce ourselves as one of the most prominent organizations to offer Bicalutamide Tablets USP 50mg which is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 metastatic carcinoma of the prostate. Our entire range is utilized to treat prostate cancer that has spread to other areas of the body. These Bicalutamide Tablets USP 50mg are tested by a team of experts on different stages to deliver the defect-free range to the customers.